Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Selling Sequenom, Inc. (SQNM)

It was a rough third quarter for many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by about 7% during the quarter. The Russell 2000, composed of smaller companies, performed even worse, trailing the S&P by about 14 percentage points between June 25 and October 30, as investors fled less-known quantities for safe havens. This was the case with hedge funds, who we heard were pulling money from the market amid the volatility, which included money from small-cap stocks, which they invest in at a higher rate than other investors. This action contributed to the greater decline in these stocks during the tumultuous period. We will study how this market volatility affected their sentiment towards Sequenom, Inc. (NASDAQ:SQNM) during the quarter below.

Sequenom, Inc. (NASDAQ:SQNM) was in 11 hedge funds’ portfolios at the end of September. Sequenom, Inc. (NASDAQ:SQNM) has experienced a decrease in enthusiasm from the smart money of late. There were 13 hedge funds in our database with Sequenom, Inc. (NASDAQ:SQNM) positions at the end of the previous quarter. At the end of this article, we will also compare Sequenom, Inc. (NASDAQ:SQNM) to other stocks, including Charter Financial Corp (NASDAQ:CHFN), Hennessy Capital Acquisition Corp (NASDAQ:BLBD), and Tribune Publishing Co (NYSE:TPUB) to get a better sense of its popularity.

Follow Sequenom Inc (NASDAQ:SQNM)
Trade (NASDAQ:SQNM) Now!

Today, there is a multitude of signals that stock market investors employ to appraise their stock investments. A pair of the best signals are hedge fund and insider trading moves. Our experts have shown that, historically, those who follow the top picks of the best money managers can outclass their index-focused peers by a solid margin (see the details here).

Keeping this in mind, let’s go over the key action regarding Sequenom, Inc. (NASDAQ:SQNM).

How are hedge funds trading Sequenom, Inc. (NASDAQ:SQNM)?

Heading into Q4, a total of 11 of the hedge funds tracked by Insider Monkey were bullish on this stock, a decline of 15% from one quarter earlier. With hedge funds’ positions undergoing their usual ebb and flow, there exists a few key hedge fund managers who were increasing their stakes significantly (or already accumulated large positions).

When looking at the institutional investors followed by Insider Monkey, Camber Capital Management, managed by Stephen DuBois, holds the largest position in Sequenom, Inc. (NASDAQ:SQNM). Camber Capital Management has a $20.6 million position in the stock, comprising 1.8% of its 13F portfolio. The second largest stake is held by Palo Alto Investors, led by William Leland Edwards, holding a $17.5 million position; 0.8% of its 13F portfolio is allocated to the company. Some other hedge funds and institutional investors that hold long positions encompass George McCabe’s Portolan Capital Management, Paul Orlin and Alex Porter’s Amici Capital and Cliff Asness’ AQR Capital Management.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.